These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 37220535)

  • 1. New insights for infection mechanism and potential targets of COVID-19: Three Chinese patent medicines and three Chinese medicine formulas as promising therapeutic approaches.
    Jia K; Li Y; Liu T; Gu X; Li X
    Chin Herb Med; 2023 Apr; 15(2):157-168. PubMed ID: 37220535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Traditional Chinese medicine for treatment of novel infectious diseases: Current status and dilemma.
    Qi F; Tang W
    Biosci Trends; 2021 Sep; 15(4):201-204. PubMed ID: 34193750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Traditional Chinese medicine to treat COVID-19: the importance of evidence-based research.
    Wang J; Qi F
    Drug Discov Ther; 2020; 14(3):149-150. PubMed ID: 32669523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential herb‒drug interactions between anti-COVID-19 drugs and traditional Chinese medicine.
    Ye L; Fan S; Zhao P; Wu C; Liu M; Hu S; Wang P; Wang H; Bi H
    Acta Pharm Sin B; 2023 Jun; 13(9):3598-637. PubMed ID: 37360014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Composition, Clinical Efficiency, and Mechanism of NHC-Approved "Three Chinese Medicines and Three Chinese Recipes" for COVID-19 Treatment.
    Xia KY; Zhao Z; Shah T; Wang JY; Baloch Z
    Front Pharmacol; 2021; 12():781090. PubMed ID: 35185537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Network pharmacology for the identification of phytochemicals in traditional Chinese medicine for COVID-19 that may regulate interleukin-6.
    Niu WH; Wu F; Cao WY; Wu ZG; Chao YC; Liang C
    Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33146673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness and Safety of Traditional Chinese Medicine in Treating COVID-19: Clinical Evidence from China.
    Xing D; Liu Z
    Aging Dis; 2021 Dec; 12(8):1850-1856. PubMed ID: 34881072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Traditional Chinese Medicine (TCM) in the treatment of COVID-19 and other viral infections: Efficacies and mechanisms.
    Huang K; Zhang P; Zhang Z; Youn JY; Wang C; Zhang H; Cai H
    Pharmacol Ther; 2021 Sep; 225():107843. PubMed ID: 33811957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Network Pharmacology Analysis to Identify Phytochemicals in Traditional Chinese Medicines That May Regulate ACE2 for the Treatment of COVID-19.
    Niu W; Wu F; Cui H; Cao W; Chao Y; Wu Z; Fan M; Liang C
    Evid Based Complement Alternat Med; 2020; 2020():7493281. PubMed ID: 33204291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chinese herbal medicine: Fighting SARS-CoV-2 infection on all fronts.
    Wang Z; Yang L
    J Ethnopharmacol; 2021 Apr; 270():113869. PubMed ID: 33485973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of seven oral traditional Chinese medicines against mild or moderate COVID-19: An updated systematic review and network meta-analysis.
    Zhang T; Li T; Zhao F; Li T; Zhang M; Jin P
    Heliyon; 2024 Aug; 10(15):e35081. PubMed ID: 39170141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A bibliometric analysis of research related Chinese Medicine in the prevention and treatment of corona virus disease 2019.
    Dayuan Z; Lan L; Luhua X; Huanjie L; Dahao C; Yumiao L; Dingxiang L; Yihui D
    Heliyon; 2022 Nov; 8(11):e11120. PubMed ID: 36278116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of registered clinical trials on traditional Chinese medicine for coronavirus disease 2019 (COVID-19): A scoping review.
    Luo H; Yang M; Tang QL; Hu XY; Willcox ML; Liu JP
    Eur J Integr Med; 2021 Jan; 41():101251. PubMed ID: 33204368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combating COVID-19 with integrated traditional Chinese and Western medicine in China.
    Ni L; Chen L; Huang X; Han C; Xu J; Zhang H; Luan X; Zhao Y; Xu J; Yuan W; Chen H
    Acta Pharm Sin B; 2020 Jul; 10(7):1149-1162. PubMed ID: 32834946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current status of traditional Chinese medicine for the treatment of COVID-19 in China.
    Chu L; Huang F; Zhang M; Huang B; Wang Y
    Chin Med; 2021 Jul; 16(1):63. PubMed ID: 34315521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential Role of Gut Microbiota in Traditional Chinese Medicine against COVID-19.
    Zhang Q; Yue S; Wang W; Chen Y; Zhao C; Song Y; Yan D; Zhang L; Tang Y
    Am J Chin Med; 2021; 49(4):785-803. PubMed ID: 33853498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Traditional Chinese Medicine as the Preventive and Therapeutic Remedy for COVID-19.
    Gasmi A; Tippairote T; Mujawdiya PK; Menzel A; Lysiuk R; Shanaida M; Lenchyk L; Peana M; Bjørklund G
    Curr Med Chem; 2024; 31(21):3118-3131. PubMed ID: 36999715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Herbal medicines exhibit a high affinity for ACE2 in treating COVID-19.
    Zhang B; Qi F
    Biosci Trends; 2023 Mar; 17(1):14-20. PubMed ID: 36596560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in the treatment of novel coronavirus disease (COVID-19) with Western medicine and traditional Chinese medicine: a narrative review.
    Al-Romaima A; Liao Y; Feng J; Qin X; Qin G
    J Thorac Dis; 2020 Oct; 12(10):6054-6069. PubMed ID: 33209439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Network pharmacology and computer-aided drug design to explored potential targets of Lianhua Qingwen and Qingfei Paidu decoction for COVID-19.
    Li L; Wang X; Guo X; Li Y; Song Q; Li A
    Front Pharmacol; 2022; 13():1013428. PubMed ID: 36210820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.